Literature DB >> 32959437

Polymicrogyria is Associated With Pathogenic Variants in PTEN.

Annapurna Poduri1,2,3, Edward Yang4,5, Christopher A Walsh6,2,7,8, Diane D Shao1,6,2, Christelle M Achkar1,2,3, Abbe Lai6, Siddharth Srivastava1,2, Ryan N Doan6, Lance H Rodan1,6,2, Allen Y Chen6,9,10.   

Abstract

OBJECTIVE: Congenital structural brain malformations have been described in patients with pathogenic phosphatase and tensin homologue (PTEN) variants, but the frequency of cortical malformations in patients with PTEN variants and their impact on clinical phenotype are not well understood. Our goal was to systematically characterize brain malformations in patients with PTEN variants and assess the relevance of their brain malformations to clinical presentation.
METHODS: We systematically searched a local radiology database for patients with PTEN variants who had available brain magnetic resonance imaging (MRI). The MRI scans were reviewed systematically for cortical abnormalities. We reviewed electroencephalogram (EEG) data and evaluated the electronic medical record for evidence of epilepsy and developmental delay.
RESULTS: In total, we identified 22 patients with PTEN pathogenic variants for which brain MRIs were available (age range 0.4-17 years). Twelve among these 22 patients (54%) had polymicrogyria (PMG). Variants associated with PMG or atypical gyration encoded regions of the phosphatase or C2 domains of PTEN. Interestingly, epilepsy was present in only 2 of the 12 patients with PMG. We found a trend toward higher rates of global developmental delay (GDD), intellectual disability (ID), and motor delay in individuals with cortical abnormalities, although cohort size limited statistical significance.
INTERPRETATION: Malformations of cortical development, PMG in particular, represent an under-recognized phenotype associated with PTEN pathogenic variants and may have an association with cognitive and motor delays. Epilepsy was infrequent compared to the previously reported high risk of epilepsy in patients with PMG. ANN NEUROL 2020;88:1153-1164.
© 2020 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32959437      PMCID: PMC7877488          DOI: 10.1002/ana.25904

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   11.274


  22 in total

1.  Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

Authors:  D J Marsh; V Coulon; K L Lunetta; P Rocca-Serra; P L Dahia; Z Zheng; D Liaw; S Caron; B Duboué; A Y Lin; A L Richardson; J M Bonnetblanc; J M Bressieux; A Cabarrot-Moreau; A Chompret; L Demange; R A Eeles; A M Yahanda; E R Fearon; J P Fricker; R J Gorlin; S V Hodgson; S Huson; D Lacombe; C Eng
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

2.  A retrospective chart review of the features of PTEN hamartoma tumour syndrome in children.

Authors:  Emily Hansen-Kiss; Sarah Beinkampen; Brent Adler; Thomas Frazier; Thomas Prior; Steven Erdman; Charis Eng; Gail Herman
Journal:  J Med Genet       Date:  2017-05-19       Impact factor: 6.318

3.  Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.

Authors:  Ghayda M Mirzaa; Robert L Conway; Karen W Gripp; Tally Lerman-Sagie; Dawn H Siegel; Linda S deVries; Dorit Lev; Nancy Kramer; Elizabeth Hopkins; John M Graham; William B Dobyns
Journal:  Am J Med Genet A       Date:  2012-01-06       Impact factor: 2.802

Review 4.  Polymicrogyria: a common and heterogeneous malformation of cortical development.

Authors:  Chloe A Stutterd; Richard J Leventer
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-05-28       Impact factor: 3.908

5.  Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.

Authors:  Jennifer E Posey; Tamar Harel; Pengfei Liu; Jill A Rosenfeld; Regis A James; Zeynep H Coban Akdemir; Magdalena Walkiewicz; Weimin Bi; Rui Xiao; Yan Ding; Fan Xia; Arthur L Beaudet; Donna M Muzny; Richard A Gibbs; Eric Boerwinkle; Christine M Eng; V Reid Sutton; Chad A Shaw; Sharon E Plon; Yaping Yang; James R Lupski
Journal:  N Engl J Med       Date:  2016-12-07       Impact factor: 91.245

6.  The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management.

Authors:  Wen-Hann Tan; Hagit N Baris; Patricia E Burrows; Caroline D Robson; Ahmad I Alomari; John B Mulliken; Steven J Fishman; Mira B Irons
Journal:  J Med Genet       Date:  2007-05-25       Impact factor: 6.318

7.  Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations.

Authors:  Adeline Vanderver; Davide Tonduti; Ilana Kahn; Johanna Schmidt; Livija Medne; Jodie Vento; Kimberly A Chapman; Brendan Lanpher; Phillip Pearl; Andrea Gropman; Charles Lourenco; John-Steven Bamforth; Cynthia Sharpe; Mercédes Pineda; Jens Schallner; Olaf Bodamer; Simona Orcesi; Saskia A J Lesnik Oberstein; Erik A Sistermans; Helger G Yntema; Carsten Bonnemann; Amy T Waldman; Marjo S van der Knaap
Journal:  Am J Med Genet A       Date:  2013-12-20       Impact factor: 2.802

8.  De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.

Authors:  Jean-Baptiste Rivière; Ghayda M Mirzaa; Brian J O'Roak; Margaret Beddaoui; Diana Alcantara; Robert L Conway; Judith St-Onge; Jeremy A Schwartzentruber; Karen W Gripp; Sarah M Nikkel; Thea Worthylake; Christopher T Sullivan; Thomas R Ward; Hailly E Butler; Nancy A Kramer; Beate Albrecht; Christine M Armour; Linlea Armstrong; Oana Caluseriu; Cheryl Cytrynbaum; Beth A Drolet; A Micheil Innes; Julie L Lauzon; Angela E Lin; Grazia M S Mancini; Wendy S Meschino; James D Reggin; Anand K Saggar; Tally Lerman-Sagie; Gökhan Uyanik; Rosanna Weksberg; Birgit Zirn; Chandree L Beaulieu; Jacek Majewski; Dennis E Bulman; Mark O'Driscoll; Jay Shendure; John M Graham; Kym M Boycott; William B Dobyns
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

9.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

View more
  1 in total

Review 1.  Teleost Fish and Organoids: Alternative Windows Into the Development of Healthy and Diseased Brains.

Authors:  Giulia Fasano; Claudia Compagnucci; Bruno Dallapiccola; Marco Tartaglia; Antonella Lauri
Journal:  Front Mol Neurosci       Date:  2022-08-11       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.